skip to Main Content

Clinical Trial Investigates Experimental Drug for Advanced Pancreatic Cancer

Newsfeed image, light gray text on dark gray background
Patients with advanced, previously treated pancreatic cancer may be eligible to participate in a new clinical trial at the NIH Clinical Center.

The pancreas, a large gland that sits behind the stomach, produces enzymes that aid digestion and hormones that regulate blood sugar. Pancreatic cancer develops when cells that make up the ducts in the pancreas start to grow out of control. Read more . . .

Back To Top